April 23, 2026 - B. Riley Securities, Inc.
("B. Riley Securities" or "BRS"), a leading full-service and research-driven
investment bank, announced that it served as exclusive financial advisor
in connection with the sale of the PoNS® (Portable Neuromodulation
Stimulator) System to Bioness Medical, Inc.
The PoNS® System is a
medical device that helps patients recovering from neurological conditions -
such as stroke, traumatic brain injury, and multiple
sclerosis -- improve their ability to walk
and maintain balance. It offers a non-surgical, non-drug
approach to rehabilitation that can be used alongside traditional physical
therapy.
Bioness Medical is a
leading provider of advanced rehabilitation technologies designed to restore
mobility, function, and independence. The acquisition expands its platform
into central neuromodulation, complementing an established portfolio that
includes the L300 Go®, H200® Wireless, and Vector® Gait & Safety
System.
B. Riley
Securities acted as exclusive financial advisor in
connection with this transaction. Our deal team was led by
Thomas McGlynn and included Elise Melconian, Noah Rich, and
Hughes Raiford.
To learn more about the
transaction, read here.
About B. Riley Securities
B. Riley Securities is a leading full-service investment bank and capital
markets provider serving companies, financial sponsors, and institutional
investors across all industry verticals. Services include initial and follow-on
offerings, debt and equity-linked solutions, institutional private placements,
merger and acquisition (M&A) advisory, corporate restructuring, and
liability management. Widely recognized for its thematic proprietary equity
research, clients benefit from the firm's extensive network, industry
expertise, and proven execution capabilities through its end-to-end
platform. For more information, visit www.brileysecurities.com.
Follow us on LinkedIn.